No Data
Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight
MediciNova Shares Are Trading Higher After the Company Announced That It Was Notified by Sanofi That the Sanofi/Novartis Litigation Was Settled.
Novavax Falls After Guidance Cut on Lower Vaccine Sales
Zucara Therapeutics Announces Strategic Investment From Sanofi as Part of US$20 Million Series B Financing
Express News | Medicinova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
No Data
No Data
